ks well where the market is stodgy and your competitors assume that regular custom equals tied income.
5.
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ng>Distinctive value. As a specific example, I give my clients a calm oasis in which to define their go
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ls, and create achievable plans, so that important work is protected from interruptions.
6. Trade-offs
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
that build value. By tuning a package of services to your customer's needs, you could create sales barr
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
iers against your competitors.
You can set a clear direction
Following your choice of mar
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ket strategy, we would then refine this material into a clear statement of intent so that your mark
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
eting plan (and business plan) can be well focused.
This might seem like hard work b
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
ut the benefits become clear as your company connects with your customer's needs and your income and profit grow
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products